Experimentally studies inhibiting of αvβ6 or αvβ8 have resulted in reduced TGFβ signaling, reduced cancer growth, reduced tumour immunosuppression and changes in the TME that suggest a less permissive environment. Here, TGFB1 is linked to neoplasm.